77.64 USD
-1.36 (-1.72%)
77.64 USD
0 (0%)
Overall HSIC gets a fundamental rating of 4 out of 10. We evaluated HSIC against 101 industry peers in the Health Care Providers & Services industry. HSIC has a medium profitability rating, but doesn't score so well on its financial health evaluation. HSIC has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year HSIC was profitable.
In the past year HSIC had a positive cash flow from operations.
HSIC had positive earnings in each of the past 5 years.
Each year in the past 5 years HSIC had a positive operating cash flow.
1.2 Ratios
The Return On Assets of HSIC (3.52%) is better than 66.34% of its industry peers.
Looking at the Return On Equity, with a value of 11.63%, HSIC is in the better half of the industry, outperforming 76.24% of the companies in the same industry.
HSIC's Return On Invested Capital of 6.64% is fine compared to the rest of the industry. HSIC outperforms 64.36% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HSIC is in line with the industry average of 9.21%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.52% | ||
| ROE | 11.63% | ||
| ROIC | 6.64% |
ROA(3y)4.67%
ROA(5y)5.33%
ROE(3y)12.83%
ROE(5y)13.8%
ROIC(3y)8.02%
ROIC(5y)8.48%
1.3 Margins
Looking at the Profit Margin, with a value of 3.02%, HSIC is in the better half of the industry, outperforming 67.33% of the companies in the same industry.
HSIC's Profit Margin has declined in the last couple of years.
The Operating Margin of HSIC (5.94%) is better than 64.36% of its industry peers.
HSIC's Operating Margin has declined in the last couple of years.
HSIC has a Gross Margin (31.19%) which is comparable to the rest of the industry.
HSIC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.94% | ||
| PM (TTM) | 3.02% | ||
| GM | 31.19% |
OM growth 3Y-5.7%
OM growth 5Y-4.55%
PM growth 3Y-15.43%
PM growth 5Y-15.06%
GM growth 3Y2.29%
GM growth 5Y0.47%
2. Health
2.1 Basic Checks
HSIC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for HSIC has been reduced compared to 1 year ago.
HSIC has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, HSIC has a worse debt to assets ratio.
2.2 Solvency
HSIC has an Altman-Z score of 2.68. This is not the best score and indicates that HSIC is in the grey zone with still only limited risk for bankruptcy at the moment.
HSIC has a Altman-Z score (2.68) which is comparable to the rest of the industry.
The Debt to FCF ratio of HSIC is 8.70, which is on the high side as it means it would take HSIC, 8.70 years of fcf income to pay off all of its debts.
HSIC has a Debt to FCF ratio (8.70) which is in line with its industry peers.
HSIC has a Debt/Equity ratio of 0.91. This is a neutral value indicating HSIC is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.91, HSIC is in line with its industry, outperforming 42.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 8.7 | ||
| Altman-Z | 2.68 |
ROIC/WACC0.76
WACC8.73%
2.3 Liquidity
HSIC has a Current Ratio of 1.40. This is a normal value and indicates that HSIC is financially healthy and should not expect problems in meeting its short term obligations.
HSIC has a Current ratio (1.40) which is in line with its industry peers.
A Quick Ratio of 0.79 indicates that HSIC may have some problems paying its short term obligations.
HSIC has a Quick ratio of 0.79. This is in the lower half of the industry: HSIC underperforms 76.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.4 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
HSIC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.49%, which is quite good.
Measured over the past 5 years, HSIC shows a small growth in Earnings Per Share. The EPS has been growing by 6.19% on average per year.
The Revenue has been growing slightly by 3.51% in the past year.
Measured over the past years, HSIC shows a small growth in Revenue. The Revenue has been growing by 4.88% on average per year.
EPS 1Y (TTM)14.49%
EPS 3Y1.6%
EPS 5Y6.19%
EPS Q2Q%13.11%
Revenue 1Y (TTM)3.51%
Revenue growth 3Y0.73%
Revenue growth 5Y4.88%
Sales Q2Q%5.2%
3.2 Future
Based on estimates for the next years, HSIC will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.14% on average per year.
Based on estimates for the next years, HSIC will show a small growth in Revenue. The Revenue will grow by 3.28% on average per year.
EPS Next Y5.85%
EPS Next 2Y6.73%
EPS Next 3Y7.97%
EPS Next 5Y8.14%
Revenue Next Year2.47%
Revenue Next 2Y2.91%
Revenue Next 3Y3.2%
Revenue Next 5Y3.28%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 16.11 indicates a correct valuation of HSIC.
Based on the Price/Earnings ratio, HSIC is valued cheaper than 80.20% of the companies in the same industry.
When comparing the Price/Earnings ratio of HSIC to the average of the S&P500 Index (27.19), we can say HSIC is valued slightly cheaper.
HSIC is valuated correctly with a Price/Forward Earnings ratio of 14.38.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HSIC indicates a somewhat cheap valuation: HSIC is cheaper than 78.22% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.88. HSIC is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.11 | ||
| Fwd PE | 14.38 |
4.2 Price Multiples
HSIC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. HSIC is cheaper than 70.30% of the companies in the same industry.
HSIC's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.67 | ||
| EV/EBITDA | 10.57 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HSIC does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of HSIC may justify a higher PE ratio.
PEG (NY)2.75
PEG (5Y)2.6
EPS Next 2Y6.73%
EPS Next 3Y7.97%
5. Dividend
5.1 Amount
HSIC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
77.64
-1.36 (-1.72%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners97.45%
Inst Owner Change0%
Ins Owners0.79%
Ins Owner Change-0.29%
Market Cap9.14B
Revenue(TTM)12.94B
Net Income(TTM)391.00M
Analysts71.82
Price Target79.3 (2.14%)
Short Float %5.73%
Short Ratio3.99
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.88%
Min EPS beat(2)-9.54%
Max EPS beat(2)5.78%
EPS beat(4)2
Avg EPS beat(4)-1.38%
Min EPS beat(4)-9.54%
Max EPS beat(4)5.78%
EPS beat(8)4
Avg EPS beat(8)-0.56%
EPS beat(12)5
Avg EPS beat(12)-0.94%
EPS beat(16)7
Avg EPS beat(16)0.24%
Revenue beat(2)0
Avg Revenue beat(2)-0.76%
Min Revenue beat(2)-1.43%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-2.59%
Min Revenue beat(4)-5.06%
Max Revenue beat(4)-0.09%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)0
Avg Revenue beat(12)-3.01%
Revenue beat(16)1
Avg Revenue beat(16)-2.68%
PT rev (1m)0.75%
PT rev (3m)5.84%
EPS NQ rev (1m)0.11%
EPS NQ rev (3m)-0.24%
EPS NY rev (1m)0.03%
EPS NY rev (3m)2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.68%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.11 | ||
| Fwd PE | 14.38 | ||
| P/S | 0.71 | ||
| P/FCF | 25.67 | ||
| P/OCF | 17.08 | ||
| P/B | 2.72 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.57 |
EPS(TTM)4.82
EY6.21%
EPS(NY)5.4
Fwd EY6.95%
FCF(TTM)3.02
FCFY3.9%
OCF(TTM)4.54
OCFY5.85%
SpS109.9
BVpS28.55
TBVpS-15.56
PEG (NY)2.75
PEG (5Y)2.6
Graham Number55.64
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.52% | ||
| ROE | 11.63% | ||
| ROCE | 9.68% | ||
| ROIC | 6.64% | ||
| ROICexc | 6.74% | ||
| ROICexgc | 16.65% | ||
| OM | 5.94% | ||
| PM (TTM) | 3.02% | ||
| GM | 31.19% | ||
| FCFM | 2.75% |
ROA(3y)4.67%
ROA(5y)5.33%
ROE(3y)12.83%
ROE(5y)13.8%
ROIC(3y)8.02%
ROIC(5y)8.48%
ROICexc(3y)8.17%
ROICexc(5y)8.74%
ROICexgc(3y)19.66%
ROICexgc(5y)20.9%
ROCE(3y)10.93%
ROCE(5y)11.41%
ROICexgc growth 3Y-9.94%
ROICexgc growth 5Y-7.93%
ROICexc growth 3Y-12.98%
ROICexc growth 5Y-8.63%
OM growth 3Y-5.7%
OM growth 5Y-4.55%
PM growth 3Y-15.43%
PM growth 5Y-15.06%
GM growth 3Y2.29%
GM growth 5Y0.47%
F-Score5
Asset Turnover1.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 8.7 | ||
| Debt/EBITDA | 2.85 | ||
| Cap/Depr | 58.69% | ||
| Cap/Sales | 1.38% | ||
| Interest Coverage | 5.16 | ||
| Cash Conversion | 49.81% | ||
| Profit Quality | 91.05% | ||
| Current Ratio | 1.4 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 2.68 |
F-Score5
WACC8.73%
ROIC/WACC0.76
Cap/Depr(3y)61.22%
Cap/Depr(5y)49.53%
Cap/Sales(3y)1.25%
Cap/Sales(5y)0.97%
Profit Quality(3y)112.93%
Profit Quality(5y)114.98%
High Growth Momentum
Growth
EPS 1Y (TTM)14.49%
EPS 3Y1.6%
EPS 5Y6.19%
EPS Q2Q%13.11%
EPS Next Y5.85%
EPS Next 2Y6.73%
EPS Next 3Y7.97%
EPS Next 5Y8.14%
Revenue 1Y (TTM)3.51%
Revenue growth 3Y0.73%
Revenue growth 5Y4.88%
Sales Q2Q%5.2%
Revenue Next Year2.47%
Revenue Next 2Y2.91%
Revenue Next 3Y3.2%
Revenue Next 5Y3.28%
EBIT growth 1Y26.48%
EBIT growth 3Y-5.01%
EBIT growth 5Y0.11%
EBIT Next Year15.49%
EBIT Next 3Y8.36%
EBIT Next 5Y7.01%
FCF growth 1Y-45.15%
FCF growth 3Y1.58%
FCF growth 5Y1.99%
OCF growth 1Y-31.93%
OCF growth 3Y6.12%
OCF growth 5Y4.66%
HENRY SCHEIN INC / HSIC FAQ
What is the ChartMill fundamental rating of HENRY SCHEIN INC (HSIC) stock?
ChartMill assigns a fundamental rating of 4 / 10 to HSIC.
What is the valuation status of HENRY SCHEIN INC (HSIC) stock?
ChartMill assigns a valuation rating of 5 / 10 to HENRY SCHEIN INC (HSIC). This can be considered as Fairly Valued.
Can you provide the profitability details for HENRY SCHEIN INC?
HENRY SCHEIN INC (HSIC) has a profitability rating of 6 / 10.
What are the PE and PB ratios of HENRY SCHEIN INC (HSIC) stock?
The Price/Earnings (PE) ratio for HENRY SCHEIN INC (HSIC) is 16.11 and the Price/Book (PB) ratio is 2.72.
What is the earnings growth outlook for HENRY SCHEIN INC?
The Earnings per Share (EPS) of HENRY SCHEIN INC (HSIC) is expected to grow by 5.85% in the next year.